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CONSPECTUS:  
 
 
 
 
The design and study of miniproteins – that is, polypeptide chains < 40 amino acids in 
length that adopt defined and stable 3D structures – is resurgent. Miniproteins offer 
possibilities for reducing the complexity of larger proteins, and so present new routes to 
studying sequence-to-structure and sequence-to-stability relationships in proteins generally. 
They also provide modules for protein design by pieces and, with this, prospects for building 
more-complex or even entirely new protein structures. In addition, miniproteins are useful 
scaffolds for templating functional domains; e.g., those involved in protein-protein interactions, 
catalysis, and biomolecular binding, leading to potential applications in biotechnology and 
medicine. 
Here we select examples from almost four decades of miniprotein design, 
development and dissection. Simply because of the word limit for these Accounts, we focus 
on miniproteins that are cooperatively folded monomers in solution and not stabilized by cross-
linking or metal binding. In these cases, the optimization of non-covalent interactions is even 
more critical for the maintenance of the folded states than in larger proteins. Our chronology 
and catalogue highlights themes in miniproteins, which we explore further and begin to put on 
a firmer footing through an analysis of the miniprotein structures that have been deposited in 
the Protein Data Bank (PDB) thus far. 
 Specifically, and compared with larger proteins, miniproteins generally have a lower 
proportion of residues in regular secondary structure elements ( helices,  strands, and 
polyproline II helices) and, concomitantly, more residues in well-structured loops. This allows 
distortions of the backbone enabling mini hydrophobic cores to be made. This also contrasts 
with larger proteins, which can achieve hydrophobic cores through tertiary contacts between 
distant regions of sequence. On average, miniproteins have a higher proportion of aromatic 
residues than larger proteins, and specifically electron-rich Trp and/or Tyr, which are often 
found in combination with Pro and Arg to render networks of CH– or cation– interactions. 
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Miniproteins also have a higher proportion of the long-chain charged amino acids (Arg, Glu, 
and Lys), which presumably reflects salt-bridge formation and their greater surface area-to-
volume ratio. Together, these amino-acid preferences appear to support greater densities of 
non-covalent interactions in miniproteins compared with larger proteins. 
 We anticipate that with recent developments such as parametric protein design, it will 
become increasingly routine to use computation to generate and evaluate models for 
miniproteins in silico ahead of experimental studies.  This could include accessing new 
structures comprising secondary structure elements linked in previously unseen 
configurations.  The improved understanding of the non-covalent interactions that stabilize the 
folded states of such miniproteins that we are witnessing through both in-depth bioinformatics 
analyses and experimental testing will feed these computational protein designs. With this in 
mind, we can expect a new and exciting era for miniprotein design, study and application.   
   
  
I. INTRODUCTION 
 
Polypeptide chains fold into myriad three-dimensional shapes determined by their 
amino acid sequences. Currently, there are approaching 120,000 protein structures in the 
Protein Data Bank (PDB), the chains of which adopt over 1300 distinct folds and have an 
average length of 800 residues. Understanding this process is known as the protein-folding 
problem,1 which has three aspects: How do proteins fold mechanistically? How do proteins 
fold in vivo? And, what information in the amino-acid sequence encodes 3D structure and 
function?2 These are complex problems because the folded states are determined by the 
interplay of many weak non-covalent interactions between thousands of atoms.3 Moreover, 
the entropic cost of folding protein chains is only just outweighed by the enthalpy of forming 
these interactions making folded proteins only marginally stable. One way to address these 
various aspects of the protein-folding problem is to study so-called miniproteins where 
complexity is reduced, providing accessible platforms for dissecting contributions to protein 
folding and stability both in silico and in vitro.4,5  
Here we define miniproteins as short proteins of 40 amino acids with well-defined 
folds consisting of two or more secondary structure elements, sequestered hydrophobic cores, 
and cooperative folding. Standalone, small and cooperatively folded secondary structures 
exist e.g., single -helical peptides,6 however these lack the hydrophobic cores typical of 
globular proteins. This definition resonates with the concept of foldamers more generally.7 
The small size of miniproteins necessarily means smaller hydrophobic cores and fewer 
non-covalent interactions than found in proteins generally. Therefore, many miniproteins are 
stabilized by metal binding or covalent cross-linking; for example, EF hands,8 zinc fingers9 and 
cysteine-knot peptides.10 Here, we focus on water-soluble and largely monomeric miniproteins 
stabilized solely by non-covalent interactions and without bound metals or covalent cross-links, 
although we recognize that great strides have been and continue to be made with these 
miniproteins more generally.11,12 We give a brief history of the sub-field, highlight key examples 
and themes in more detail, and tease out rules for miniprotein design supported by an analysis 
of the PDB. Finally, we discuss potential applications and outlook for miniproteins.  
Many of the miniproteins described over the last four decades are fragments of larger 
globular proteins and have been subject to iterative redesign and optimization to enhance 
stability and impart function.5,13-15 Successes in this have taught us some general rules of 
thumb for miniprotein design that we discuss with examples here. However, and despite this, 
the field of miniprotein design is far from mature. 
Most recently, high-throughput methods have been applied to miniprotein design.16,17 
This starts with fragment-based computational design of backbones followed by the 
generation of libraries of best-fitting sequences. Experimentally, the miniprotein libraries are 
displayed on yeast and unstable and stable variants are distinguished by protease treatment 
and then identified by fluorescence-activated cell sorting and deep sequencing.  This reveals 
sequence-to-stability relationships, which, reassuringly, mirror some well-established rules of 
protein folding. 
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II. A CHRONOLOGY AND COLLECTION OF MINIPROTEINS 
 
PANCREATIC POLYPEPTIDES 
The polyproline II:loop:-helix fold was first observed in the X-ray crystal structure of 
avian pancreatic peptide hormone (aPP) dimer.18 This compact fold is stabilized by the 
interdigitation of proline residues from the polyproline-II helix with aromatic residues presented 
by the  helix to form a hydrophobic core, and in addition -stacking interactions stabilize the 
dimer interface, Figure 1. Recently, we have designed a monomeric 34-residue miniprotein 
with the same overall topology of the pancreatic polypeptides,19 which we call PP and discuss 
later, Figures 2A&3.  
Directed evolution of synthetic aPP monomers has been used to develop miniprotein-
based ligands as therapeutics. Optimization of the polyproline II helix in aPP gave a variant 
with high affinity for the ActA target protein in Listeria monocytogenes, EVH1 mena1-112. 
Importantly, the miniprotein discriminates between paralogs and reduces bacterial motility.13 
A similar strategy has been used to optimize the -helix of aPP for sequence-specific DNA 
recognition,14 and the introduction of arginine residues in aPP facilitates transport of the 
miniprotein into cells.20 Artificial esterases have also been developed by grafting catalytic 
residues onto the solvent-exposed  helix of bovine pancreatic polypeptide, bPP.21 
 
 
Figure 1: Timeline of miniprotein discovery. Structures are colored by secondary structure: red,  helix; 
yellow,  strand; dark gray, polyproline II helix; violet, 310 helix; and green, loop. Annotations: year published; 
structure type; PDB code; and number of residues. Structures are oriented NC terminus left to right. * = X-ray 
crystal structure, all others are solution NMR structures. †See reference 22. 
 
 
 FOLDS & METAL-FREE ZINC FINGERS 
Small, independent  units are best exemplified by DNA-binding zinc fingers. These 
were first identified in transcription factor IIIA from Xenopus oocytes, and an NMR structure 
determined for the Xfin domain followed.23 The fold, which comprises a  hairpin, a connecting 
loop, and an  helix, is not driven by the conserved hydrophobic core but by the binding of 
zinc usually through His2Cys2 motifs. The development and modular assembly of metal-
binding zinc-finger domains has created artificial proteins and enzymes that can recognize 
defined regions of DNA for the activation, repression or alteration of user-specified genes, and 
has contributed early in the development of genome editing.24 
Regarding metal-free designs, a 23-residue monomeric structure has been achieved 
through iterative design enhancing a hydrophobic core, -helix structure and inclusion of a 
suitable turn;25 and a computational design has produced a weakly cooperatively folded 
peptide with a midpoint of unfolding (TM) of 39C.26  The broad transition is consistent with a 
low enthalpy of folding expected for a small hydrophobic core.  
 
VILLIN HEADPIECE 
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Another approach to miniprotein design is to pare down larger natural proteins.  The 
Villin headpiece, a 35-residue fragment of the chicken protein (HP-35), folds in water.27 The 
NMR ensemble reveals three -helical segments with each helix contributing residues to a 
central hydrophobic core.27 HP-35 is surprisingly thermostable with a TM of 70C.28  
 
 
 
 
Figure 2: Miniprotein structures. A: PP-Tyr (PDB: 5LO2).19 B:  metal-free zinc finger (PDB: 1PSV).26  C: 
Villin headpiece (PDB: 1YRI).28 D: Trp-zipper -hairpin (PDB: 1LE3).29 E: Protype WW domain (PDB: 1E0M).30 
F: Trp-cage (PDB: 2J0F).31 G:  (PDB: 2KI0). H: TrpPlexus.22 Structures are oriented NC terminus left to 
right. Key: aromatics Trp, Tyr and Phe, green; Pro, yellow and Arg, light blue. 
 
 
-HAIRPINS AND TRP-ZIPPERS 
  Early examples of free-standing -structures based on natural fragments were only 
moderately folded in fully aqueous media.32,33 However, designed Trp-zippers are well-folded 
examples of short (12 to 16 residues) de novo  hairpins with interlocked Trps and right-
handed highly-twisted strands, Figure 2D.29 They have exceptional thermal stabilities and 
reversible cooperative unfolding.  
Trp-pocket  hairpins are stabilized via cation– interactions in which a single Lys 
packs against a diTrp cleft on the opposite strand.34 Some 12-residue Trp-pockets are fully 
folded34 and resist degradation,35 making them the most stable  hairpins reported. 
From a wealth of studies, reliable guidelines for the design, optimization and 
stabilization of monomeric -hairpins include: a hydrophobic cluster on one surface of the 
hairpin and close to the loop;36 inter-strand side-chain interactions, particularly Trp-Trp;29,37 
high turn and -sheet propensities;38 and charged or aromatic residues, or -capping motifs 
to secure the termini via cross-strand interactions.39  
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DESIGNED THREE-STRANDED -SHEETS 
 
A challenge in the design of isolated -sheets is to avoid -amyloid-like assemblies.40 
Some tentative three-stranded antiparallel -sheets have been achieved in aqueous methanol 
by appending strands onto -hairpins.41 An early NMR structure of ‘Betanova’ in water 
incorporates an aromatic-rich hydrophobic cluster on one surface of the sheet.42 However, 
subsequent studies indicate only partial folding, though improved stability has been achieved 
by computationally informed mutations.43  
 Protein redesign presents another route to -sheet miniproteins. WW domains are 
natural antiparallel 3-stranded  sheets, named after the two conserved Trp residues in the 
first and third  strands.44 X-ray crystal structures of two shorter (34 and 37 residues) natural 
WW domains followed, in addition to that for a designed 33-residue prototype, Figure 2E.30 
Natural WW domains have been engineered for alternative functions; e.g., the incorporation 
of a DNA binding pocket,15 and for probing carbohydrate-aromatic packing interactions.5  
 
TRP-CAGE 
The Trp-cage is a 20-residue miniprotein from the glia monster extendin-4.45 The 
original truncation is only folded in aqueous trifluoroethanol.45 However, NMR structures of 
variants show a well-ordered fold comprising an  helix followed by a well-structured loop, 
with a hydrophobic core centered on a single Trp residue buttressed by Pro side chains, Figure 
2F.31 Owing to its small size and wealth of experiment data now available, the Trp-cage has 
become a paradigm for experimental and computational miniprotein folding.46  
 
 DESIGNS 
 ()n repeats occur widely in natural proteins, e.g. TIM barrels, the Rossmann fold, 
and Leucine Rich Repeats. The alternating secondary structure elements leads to parallel -
sheets. The first de novo designed, standalone, water-soluble  unit comprises a 12-residue 
 helix paired with two 5-residue  strands via a small hydrophobic core.47 Although initial 
designs are molten globule, a folded state has been stabilized by installing a Trp-zip-like Trp 
pair in the -strands.29 An NMR structure of the resulting 36-residue  construct (Figure 2G) 
confirms face-to-face packing of the installed pair. The miniprotein is highly stable up to 
temperatures of 90C, which is remarkable for a small miniprotein with only proteinogenic 
amino acids and without covalent cross-links.  
 
TRP-PLEXUS 
The first miniprotein comprising a -strand and a polyproline II helix has been achieved 
through a fragment-based design, Figure 2H.22 TrpPlexus combines a short, Arg-rich, N-
terminal  strand, and a C-terminal polyproline II helix that is free of Pro but rich in Trp in a 
WSXWS motif.  These are borrowed from a fibronectin III binding domain, and linked by a D-
Pro-Gly loop to give a 19-residue construct. NMR spectroscopy shows the Arg and Trp 
residues interdigitate to form a cation– network.22 A disulfide-cyclized TrpPlexus tolerates N-
substituted Gly and Pro residues in the polyproline II helix, opening up potential for 
proteinogenic and peptoid side-chain placements for peptidomimetic inhibitors of protein-
protein interactions.48 
 
PP 
Recently we combined fragment-based and rational design to create the monomeric 
miniprotein, PP.19 PP comprises a polyproline II helix:loop:-helix topology that is stabilized 
by interdigitation of Pro residues of the polyproline helix into aromatic residues presented by 
the -helix, similar to knobs-into-holes interactions found in coiled coils, Figure 3. The helices 
were borrowed from the bacterial adhesin AgI/II49 and an intervening loop from a pancreatic 
polypeptide.50 We selected ≈6 turns of  helix to partner ≈3 turns of polyproline helix and to 
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maintain knobs-into-holes-like interactions along the lengths of both helices. The tyrosine 
variant, PP-Tyr, is water soluble, monomeric and unfolds cooperatively with a TM of 39C.  
 
 
 
Figure 3: Design of PP combining polyproline II and -helices. A&B: 2D helical net representations (i.e. C 
atoms mapped onto cylinder of appropriate radii) of a canonical polyproline II helix (A) and -helix (B) and C: 
these two nets overlaid showing ‘knobs-into-holes’ packing of Pro and Tyr side chains. D: Representative NMR 
structure of PP-Tyr showing the CH– interactions found (PDB: 5LO2).19 Figure adapted from reference 19.  
 
 
An NMR structure reveals intimate CH– interactions51 between the proline and 
aromatic side chains, Figure 3D. We have explored the importance of these interactions by 
mutating the three parent tyrosine residues to para-substituted phenylalanine residues with 
varying ring electron densities. These experiments highlight electronic and electrostatic 
contributions to the interaction beyond van der Waals’ contacts, as the more electron-rich 
aromatics lead to more stable PP variants. Interestingly, of the proteinogenic aromatic side 
chains, Pro-Tyr and Pro-Trp interactions gave PP variants with similar thermal stabilities. 
This corroborates our bioinformatics analyses of the PDB which highlights a preference for 
CH– interactions between Pro and the electron-rich aromatics but not Phe.19 
 
 
III. COMMON FEATURES: BIOINFORMATICS ANALYSIS OF MINIPROTEINS IN THE PDB 
 
The above examples hint at common features that relate miniprotein sequence, 
structure and stability. For example, the importance of large aromatics, particularly Trp, in the 
hydrophobic cores of miniproteins. To explore this, and to seek other sequence-to-structure 
relationships, we performed a comparative bioinformatics analysis of the mini- and large 
proteins in the PDB. For this, we culled a non-redundant database of X-ray crystal and solution 
NMR structures of miniproteins of  40 residues and with  40% pairwise sequence identity, 
Figure 4; and a set of larger proteins with  100 residues and high-resolution ( 1.0 Å) X-ray 
crystal structures. We verified our set of miniproteins contained only monomeric structures 
determined in aqueous media.  
First, we compared the amino-acid compositions of the two sets, Figure 5. Miniproteins 
use three classes of amino acids more often than the larger proteins: long and/or charged 
amino acids, e.g., Arg, Glu, Lys, Met (and to a lesser extent His); electron-rich aromatics, Trp 
and Tyr, with Trp showing a preference for miniproteins twice that of larger proteins; and Pro. 
In contrast, small amino acids and the aliphatic hydrophobics are found more often in the 
larger proteins. This suggests that the polar aromatics, and longer charged amino acids 
provide routes to good non-covalent interactions; i.e., salt bridges, and CH– and cation– 
interactions; and that Pro helps reduce the entropic cost of folding as well as buttressing 
aromatics in the core. 
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Figure 4: Non-redundant miniproteins. X-ray crystal and solution NMR structures of miniproteins downloaded 
from the PDB on 23/02/2017. Structures are arranged loosely by conformation, and oriented NC terminus left 
to right. For the solution-phase structures, this set includes only those determined in purely aqueous media. Key: 
 helix, red;  strand, yellow; loop, green; and polyproline II helix, gray. N.B. DSSP assigns some regions of  
hairpins and three-stranded  sheets as unstructured (green).  
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Figure 5: Amino-acid usage in miniproteins vs. larger proteins. These were calculated as the log10 ratio of 
the normalized propensity of amino acids in miniproteins (n = 55) vs. proteins  100 residues long (n = 120) 
Ratios of 0.3 indicate a two-fold preference (long dashed lines); 0.2 a 1.6-fold preference (short dashed lines); 
and 0.1 a 1.3-fold preference (dotted lines). Amino acids are ordered by increasing side chain volume.  
 
 
We have also examined secondary structure content using the Define Secondary 
Structure of Proteins (DSSP) algorithm, Figure 4.52 This revealed similar proportions of  helix 
in miniproteins and larger proteins; but less  strand in the former (with the exception of the 
water-soluble -hairpins and three-stranded -sheets, of course). It is possible that this is due 
to bias in the dataset rather than miniprotein requirements. Also, it appears that miniproteins 
have more-contorted backbones and make better use of structured loops to best sequester 
hydrophobics within their interiors. Concomitant with reduced regular secondary structures, 
we found fewer main chain-main chain hydrogen bonds in miniproteins, with half of the 
residues making these compared with approximately three quarters in larger proteins. The 
shortfall in miniproteins is likely made up by more hydrogen bonds to water, as their small size 
gives greater surface area-to-volume ratios. 
So how are miniproteins stabilized? True, the overall entropic cost of folding a 
minoprotein might be lower than for larger proteins, but it will still be unfavorable and will have 
to be recouped by enthalpically favorable interactions.  However, it is clear that fewer such 
interactions are made in miniproteins as they generally have broader thermal unfolding 
transitions than larger proteins.19  Nonetheless, there must be favorable non-covalent 
interactions to outweigh the T∆S term of folding. To address this, we are actively interrogating 
the above databases for sequence-to-structure/stability relationships. It is early in this analysis, 
but trends are emerging. For example, we find that when normalized for length miniproteins 
make up to eight times as many salt bridges than their longer counterparts; and when 
normalized for both length and number of aromatic residues miniproteins are approximately 
six-times denser in CH– interactions.  
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IV: OUTLOOK 
We have attempted to cover four decades of miniprotein research in a 6,000-word 
Account. As a result, we have had to omit many of the fascinating aspects of these studies, 
including details of the approaches taken, the experimental and theoretical methods used, the 
sequences explored, and the nuances of the results obtained. However, we hope to have 
conveyed two main aspects of miniprotein research and development that others may find 
useful, namely: first, a chronology and overview of miniprotein discovery and, with it, the 
design and engineering approaches taken to reveal them; and, second, common sequence 
and structural features found in miniproteins through these studies and our own, albeit 
preliminary, bioinformatics analysis of the RCSB PDB.  
On the latter, sequence-to-structure/stability relationships are clearly emerging for 
miniprotein folding.  Moreover, these are being discussed and, indeed, understood in terms of 
the non-covalent interactions that underpin them.  For miniproteins, and mostly in contrast to 
what is possible with larger proteins, these interactions can be probed with atomic resolution 
using synthetic peptide chemistry: non-proteinogenic amino acids can be introduced into 
miniproteins, and principles and methods from physical organic chemistry can be used to 
rationalize their impact on structure and stability.5,19  Such knowledge and understanding will 
not only illuminate how miniproteins are stabilized but also how protein structures are specified 
and maintained in general.5,19,53,54 In turn, this will undoubtedly improve our abilities to engineer 
existing miniproteins and to design new examples of these de novo.  We anticipate that, along 
with the in biro and rational design approaches that have been favored to date, parametric 
computational protein design will become increasingly used to deliver new miniproteins.  Here, 
a challenge for the protein-design community will be to make their methods more available to 
non-expert users. 
One thing that we have neglected in this Account is the potential to functionalize 
miniproteins for both basic and applied research; we have had to focus on structures and 
sequence-to-structure/stability relationships rather than on structure-function relationships.  
Many have contributed to this important aspect of the field.5,13-15 For example, miniproteins 
provide scaffolds onto which functional motifs can be grafted.14,55  The most clear-cut 
application here is the introduction of binding and recognition motifs, for example to interfere 
with protein-protein interactions. In addition, and although more challenging, there are 
prospects for introducing catalytic functions into simplified peptide and protein 
architectures.14,21 With the array of structures that we have presented and others that are 
coming online, and with the underpinning thermodynamic understanding of these, we 
anticipate further and considerable advances on this road to functional miniproteins.    
Finally, and particularly exciting to us, is the concept that miniproteins might be used 
as building blocks to design and engineer entirely new protein folds.  This might be termed 
proteins from peptides (we thank Andrei Lupas for this phrase) or protein design by pieces.56-
58  It offers routes into what is being called the dark matter of protein fold space,59 and, thus, 
into a truly synthetic biology.60    
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